Free website offers chemo order forms
Georgia Cancer Specialists (GCS), a large Atlanta-based oncology practice, has made available a free website, ChemoOrders.com, offering chemotherapy protocol order forms.
ATLANTAGeorgia Cancer Specialists (GCS), a large Atlanta-based oncology practice, has made available a free website, ChemoOrders.com, offering chemotherapy protocol order forms.
ChemoOrders.com creates patient-specific chemotherapy orders and supporting documents based on physician- or nurse-entered vital signs and disease parameters, GCS said in a press release. The site is modeled after a disease management system GCS developed and has used in patient care for several years. The protocols are created using established peer-reviewed clinical guidelines.
"Most oncologists practice the same way they have for 20 years, trusting their memories and nurses' support to prescribe and manage treatment," said Bruce Feinberg, MD, GCS president and CEO. "The ever-growing complexity of cancer management makes this approach increasingly risky for both patient and provider." The site also provides print-ready chemotherapy flow sheets, informed consents, and patient education materials. "We want to provide touch-of-a-button access to everything patients and doctors need for successful treatment," Dr. Feinberg said.
MammoScreen AI Tool Improves Diagnostic Performance of Radiologists in Detecting Breast Cancer
December 16th 2020This study demonstrated that the concurrent use of this new artificial intelligence tool alongside mammography improved the diagnostic performance of radiologists in the detection of breast cancer without prolonging their workflow.
Preliminary Results Suggest AB-MR Detects Breast Cancers that 3-D Mammograms May Miss
November 29th 2020This study found that abbreviated breast magnetic resonance imaging as a supplemental screening test in women with dense breasts shows an increase in cancer detection over digital breast tomosynthesis screening.
DeepSurv Displays Possible Benefits in Prognostic Evaluation, Treatment Recommendation
July 20th 2020The deep learning survival neural network model demonstrated the potential to provide personalized treatment recommendations based on real clinical data in patients with non-small cell lung cancer.
